Louis Perol

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

Journal: Blood advances

Published: July 29, 2024

Prospective evaluation of bleeding risk among thrombocytopenic patients admitted in intensive care unit.

Prospective evaluation of bleeding risk among thrombocytopenic patients admitted in intensive care unit.

Journal: Journal of critical care

Published: January 31, 2023

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).

Journal: Haematologica

Published: September 26, 2022

Anti-PD1-R checkpoint inhibitor related severe relapsing myelitis.

Anti-PD1-R checkpoint inhibitor related severe relapsing myelitis.

Journal: Acta neurologica Belgica

Published: April 19, 2020

Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients.

Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients.

Journal: Nature communications

Published: January 24, 2020

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.

Journal: Leukemia & lymphoma

Published: February 19, 2019

Loss of immune tolerance to IL-2 in type 1 diabetes.

Loss of immune tolerance to IL-2 in type 1 diabetes.

Journal: Nature communications

Published: March 14, 2016

New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2.

New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 05, 2015

Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.

Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: February 04, 2015

Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease.

Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease.

Journal: Immunology letters

Published: September 17, 2014

Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cells.

Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cells.

Journal: Brain, behavior, and immunity

Published: August 21, 2014

Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes.

Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes.

Journal: Diabetes

Published: May 15, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026